Angiogenesis with recombinant fibroblast growth factor-2 for claudication.
Williams
David
D
Davenport
Kim
K
Tan
Yih
Y
D016222:Fibroblast Growth Factor 2 / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy / Q000628:therapy*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D015203:Reproducibility of Results; D016138:Walking
D016222:Fibroblast Growth Factor 2